Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Measles vaccination immunotherapy in adults with atopic dermatitis
2007-007267-25Phase 3Completed
- Sponsor
- Inserm
- Start
- Feb 2008
- Modality
- Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3 trial of measles virus vaccine live in atopic dermatitis (AD), sponsored by Inserm. Primary endpoint: Change in serum CCL17 and CCL18 levels. Started Feb 2008; status: completed.
02
Drugs
measles virus vaccine live
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on 2007-007267-25.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007267-25.